PYQUVI 22.75 mg/mL
deflazacort · SUSPENSION · Aucta Pharmaceuticals, Inc.
No Recall History
Plain English
PYQUVI is a suspension containing deflazacort at 22.75 mg/mL, taken oral. Manufactured by Aucta Pharmaceuticals, Inc..
Key Facts
- Brand Name
- PYQUVI
- Generic Name
- deflazacort
- NDC Code (Product)
73289-0089- Manufacturer
- Aucta Pharmaceuticals, Inc.
- Strength
- 22.75 mg/mL
- Dosage Form
- SUSPENSION
- Route
- ORAL
- Marketing Status
- Application #
- ANDA219417
- Drug Class
- Corticosteroid [EPC]
- Marketing Start
- 06/30/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is PYQUVI used for?
PYQUVI contains deflazacort. It is a suspension taken oral. Consult your doctor for specific uses.
Is PYQUVI a controlled substance?
PYQUVI is not classified as a controlled substance by the DEA.
What is the generic name for PYQUVI?
The generic name for PYQUVI is deflazacort. There are 12 other brand versions of deflazacort.
What is the NDC code for PYQUVI 22.75 mg/mL?
The NDC (National Drug Code) for PYQUVI 22.75 mg/mL is 73289-0089, listed by Aucta Pharmaceuticals, Inc..